In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10626812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor

  2005cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• The role of cytokines in both the normal and malignant ovary.

  1999cited by this paper
• Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.

  1999cited by this paper
• Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor.

  1998influential reference
• RT-PCR quantitation of cytokine responses in vivo from specimens containing small numbers of cells during bioimmunotherapy.

  1998cited by this paper
• Receptor-mediated endocytosis of decorin: involvement of leucine-rich repeat structures.

  1998cited by this paper
• Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour‐infiltrating lymphocyte (TIL)‐derived T cell lines and established tumour cell lines

  1998cited by this paper
• Decorin gene transfer-mediated suppression of TGF-β synthesis abrogates experimental malignant glioma growth in vivo

  1998cited by this paper
• Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.

  1997cited by this paper
• Reversal of Tumor-Induced Immunosuppression: A New Approach to Cancer Therapy

  1997cited by this paper
• Decorin inhibits cell attachment to thrombospondin‐1 by binding to a KKTR‐dependent cell adhesive site present within the N‐terminal domain of thrombospondin‐1

  1997cited by this paper
• Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA‐restricted cytotoxic T cells

  1997cited by this paper
• In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta.

  1997cited by this paper
• Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.

  1997cited by this paper
• The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.

  1997cited by this paper
• Reversal of in vivo drug resistance by the transforming growth factor‐β inhibitor decorin

  1997influential reference
• Human ovarian cancer of the surface epithelium.

  1997cited by this paper
• Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.

  1997cited by this paper
• Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.

  1997cited by this paper
• Transforming growth factor-β in in vivo resistance

  1996cited by this paper
• Absence of constitutive EGF receptor activation in ovarian cancer cell lines.

  1996cited by this paper
• Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer.

  1996cited by this paper
• Transforming growth factor-beta in in vivo resistance.

  1996cited by this paper
• Decorin-induced Growth Suppression Is Associated with Up-regulation of p21, an Inhibitor of Cyclin-dependent Kinases*

  1996cited by this paper
• Expression of transforming growth factor‐beta (TGF‐β) receptors, TGF‐β1 and TGF‐β2 production and autocrine growth control in osteosarcoma cells

  1994cited by this paper
• Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

  1994influential reference
• Transforming growth factor‐beta inhibits proliferation of human ovarian cancer cells obtained from ascites

  1994cited by this paper
• Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells.

  1994cited by this paper
• Analysis of p53 transactivation through high-affinity binding sites.

  1993cited by this paper
• Transforming growth factor-beta complexes with thrombospondin.

  1992cited by this paper
• Ovarian cancer. The most lethal gynecologic malignancy.

  1992cited by this paper
• Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

  1992cited by this paper
• Ovarian cancer. The most lethal gynecologic malignancy.

  1992cited by this paper
• Negative regulation of transforming growth factor-beta by the proteoglycan decorin.

  1990cited by this paper
• Negative regulation of transforming growth factor-β by the proteoglycan decorin

  1990cited by this paper
• A Laboratory manual

  1989cited by this paper
• Transforming growth factor alpha (TGF alpha) induction of C-FOS and C-MYC expression in C3H 10T1/2 cells.

  1988cited by this paper
• Transforming growth factor alpha (TGFα) induction of c-fos and c-myc expression in C3H 10Tl/2 cells

  1988cited by this paper
• Criteria for analyzing interactions between biologically active agents.

  1981cited by this paper
• Characterization of an ovarian carcinoma cell line

  1978cited by this paper

• Interactions between small leucine-rich proteoglycans and proteases: implications for tissue homeostasis and pathology.

  2026cites this paper
• RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin

  2024cites this paper
• Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets

  2023cites this paper
• Maternally Expressed Gene 3 negatively regulated Decorin to Supresse Angiogenesis, Proliferation and Migration of Endothelial Cells.

  2022cites this paper
• Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer

  2021cites this paper
• Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients.

  2021cites this paper
• Metabolic Disorder of Extracellular Matrix Mediated by Decorin Upregulation Is Associated With Brain Arteriovenous Malformation Diffuseness

  2020cites this paper
• Decorin in the Tumor Microenvironment.

  2020cites this paper
• Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma

  2020cites this paper
• Tumor-specific inhibitory action of decorin on different hepatoma cell lines.

  2019cites this paper
• Association of matrix metalloproteinase-9 and decorin expression with the infiltration of cervical cancer.

  2018cites this paper
• Decorin‐mediated oncosuppression – a potential future adjuvant therapy for human epithelial cancers

  2018cites this paper
• Antiangiogenic mechanisms and factors in breast cancer treatment

  2016cites this paper
• Matricellular proteins as regulators of cancer metastasis to bone.

  2016cites this paper
• Mechanisms of trophoblast migration, endometrial angiogenesis in preeclampsia: The role of decorin

  2016cites this paper
• Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study

  2015cites this paper
• The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle

  2015cites this paper
• Identifying and Predicting the Effectiveness of Carboplatin In Vivo and In Vitro and Evaluating its Combination with Paclitaxel

  2015cites this paper
• Proteoglycan form and function: A comprehensive nomenclature of proteoglycans

  2015cites this paper
• Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts

  2015influential citation
• Decorin induced by progesterone plays a crucial role in suppressing endometriosis

  2014cites this paper
• The inhibitory effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts

  2014cites this paper
• Stromal reengineering to treat pancreas cancer.

  2014cites this paper
• Decorin and biglycan immunolocalization in non‐villous structures of healthy and pathological human placentas

  2014cites this paper
• Sulfated sugars in the extracellular matrix orchestrate ovarian cancer development: 'when sweet turns sour'.

  2014cites this paper
• Dichotomy of decorin activity on the insulin‐like growth factor‐I system

  2013cites this paper
• Breast cancer normalization induced by embryonic mesenchyme is mediated by extracellular matrix biglycan.

  2013cites this paper
• Identification of ovarian genes regulated by follicle-stimulating hormone (Fsh) in vitro during early secondary oocyte growth in coho salmon.

  2013cites this paper
• Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics

  2013cites this paper
• An essential role for decorin in bladder cancer invasiveness

  2013cites this paper
• More than matrix: the multifaceted role of decorin in cancer.

  2013cites this paper
• HER-2/neu-mediated Down-regulation of Biglycan Associated with Altered Growth Properties*

  2012cites this paper
• Small Leucine-Rich Proteoglycans

  2011cites this paper
• Quantification of Collagen Organization and Extracellular Matrix Factors within the Healing Ligament

  2011cites this paper
• Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling*

  2011cites this paper
• Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting

  2010cites this paper
• Expressão de pequenos proteoglicanos ricos em leucina: decorim e biglicam, em placentas humanas a termo normais e com alterações da invasividade trofoblástica.

  2009cites this paper
• Maturation of the extracellular matrix and cell adhesion molecules in layered co-cultures of HepG2 and endothelial cells.

  2009cites this paper
• Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation.

  2008cites this paper
• Overexpression of decorin induces apoptosis and cell growth arrest in cultured rat mesangial cells in vitro

  2008cites this paper
• Decorin suppresses lung metastases of murine osteosarcoma.

  2008cites this paper
• Tumor microenvironment: Modulation by decorin and related molecules harboring leucine‐rich tandem motifs

  2008cites this paper
• Decorin-Induced Growth Inhibition Is Overcome through Protracted Expression and Activation of Epidermal Growth Factor Receptors in Osteosarcoma Cells

  2008cites this paper
• Structural Analysis of Chondroitin Sulfate Disaccharides by Electrospray Ionization High Capacity Ion Trap Mass Spectrometry

  2008cites this paper
• Decorin-Mediated Effects in Cancer Cell Biology

  2008cites this paper
• Differential gene expression analysis of ovarian cancer in a population isolate.

  2008cites this paper
• Activation of hepatic stellate cells under hypoxia and the inhibition of HSCs activation by TGF-b binding protein Decorin

  2007cites this paper
• Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.

  2007cites this paper
• A role for decorin in cutaneous wound healing and angiogenesis

  2006cites this paper
• Extracellular Matrix of Ovarian Tumors

  2006cites this paper
• Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatin

  2006cites this paper
• Extracellular matrix of ovarian tumors.

  2006cites this paper
• Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer

  2006cites this paper
• A Novel 110-kDa Receptor Protein is Involved in Endocytic Uptake of Decorin by Human Skin Fibroblasts

  2006cites this paper
• Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress

  2006cites this paper
• Decorin Protein Core Inhibits in Vivo Cancer Growth and Metabolism by Hindering Epidermal Growth Factor Receptor Function and Triggering Apoptosis via Caspase-3 Activation*

  2006cites this paper
• Decorin Evokes Protracted Internalization and Degradation of the Epidermal Growth Factor Receptor via Caveolar Endocytosis*

  2005cites this paper
• Recovery of the Decorin-Enriched Fraction, Extract (D), From Human Skin: An Accelerated Protocol

  2004cites this paper
• Overexpressed Decorin in Pancreatic Cancer

  2004cites this paper
• Pancreatic tumor cells influence the composition of the extracellular matrix.

  2004cites this paper
• Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells

  2004cites this paper
• Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta

  2004cites this paper
• The small leucine-rich proteoglycan lumican inhibits melanoma progression.

  2004cites this paper
• Extracellular matrix signaling through growth factor receptors during wound healing

  2004cites this paper
• Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty.

  2003cites this paper
• Reversal of Tumor-induced Immunosuppression by TGF-β Inhibitors

  2003cites this paper
• DNA-binding agents.

  2003cites this paper
• In vivo selective and distant killing of cancer cells, using adenovirus‐mediated decorin gene transfer

  2003cites this paper
• Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

  2003cites this paper
• The role of decorin in collagen fibrillogenesis and skin homeostasis

  2002cites this paper
• Control of Proliferation, Migration, and Invasiveness of Human Extravillous Trophoblast by Decorin, a Decidual Product1

  2002cites this paper
• Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin

  2002cites this paper
• Decorin Binds to a Narrow Region of the Epidermal Growth Factor (EGF) Receptor, Partially Overlapping but Distinct from the EGF-binding Epitope*

  2002cites this paper
• The expression of decorin in human ovarian tumors.

  2002cites this paper
• DNA-binding agents.

  2002cites this paper
• Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.

  2002cites this paper
• Genetic analysis of early- versus late-stage ovarian tumors.

  2001cites this paper
• TRANSFORMING GROWTH FACTOR BETA MAY ACT AS AN AUTOCRINE-SURVIVAL–PROMOTING FACTOR FOR TRANSFORMED TROPHOBLASTS

  2001cites this paper
• Transforming growth factor beta may act as an autocrine-survival-promoting factor for transformed trophoblasts

  2001cites this paper
• Glycobiological strategies to inhibit the proliferative potential of ErbB receptors in human cancer

  2001cites this paper
• Sustained Down-regulation of the Epidermal Growth Factor Receptor by Decorin

  2000cites this paper
• An Anti-oncogenic Role for Decorin

  2000cites this paper
• Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecan

  2000cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  year unknowncites this paper